These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 21206344)
21. Stress in women: metabolic syndrome and polycystic ovary syndrome. Diamanti-Kandarakis E; Economou F Ann N Y Acad Sci; 2006 Nov; 1083():54-62. PubMed ID: 17148733 [TBL] [Abstract][Full Text] [Related]
22. [Polycystic ovarian syndrome is a health risk]. Hippeläinen M Duodecim; 2002; 118(10):981-3. PubMed ID: 12238006 [No Abstract] [Full Text] [Related]
29. Cardiovascular risk factors in the metabolic syndrome: impact of insulin resistance on lipids, hypertension, and the development of diabetes and cardiac events. Zarich SW Rev Cardiovasc Med; 2005; 6(4):194-205. PubMed ID: 16379015 [TBL] [Abstract][Full Text] [Related]
30. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk. Chan JC; Tong PC; Critchley JA Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595 [TBL] [Abstract][Full Text] [Related]
31. Identification of appropriate patients for cardiometabolic risk management. Peters AL Rev Cardiovasc Med; 2007; 8 Suppl 4():S9-16. PubMed ID: 17934394 [TBL] [Abstract][Full Text] [Related]
32. Polycystic ovary syndrome in obese adolescents. Stanley T; Misra M Curr Opin Endocrinol Diabetes Obes; 2008 Feb; 15(1):30-6. PubMed ID: 18185060 [TBL] [Abstract][Full Text] [Related]
33. Polycystic ovary syndrome, obesity and insulin resistance: the new female triad. Murray R Adv Nurse Pract; 2004 Aug; 12(8):22-35; quiz 36. PubMed ID: 15354503 [No Abstract] [Full Text] [Related]
34. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome. Verit FF Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438 [TBL] [Abstract][Full Text] [Related]
35. Insulin resistance syndrome and polycystic ovary syndrome: implications for diagnosis and treatment. Tan S; Hahn S; Janssen OE Panminerva Med; 2005 Dec; 47(4):211-7. PubMed ID: 16489320 [TBL] [Abstract][Full Text] [Related]
36. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Adiels M; Olofsson SO; Taskinen MR; Borén J Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1225-36. PubMed ID: 18565848 [TBL] [Abstract][Full Text] [Related]